Skip to main navigation Skip to search Skip to main content

N-Acetylaspartate and N-Acetylaspartylglutamate in Central Nervous System Health and Disease

  • John R. Moffett*
  • , Prasanth Ariyannur
  • , Peethambaran Arun
  • , Aryan M.A. Namboodiri
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

15 Scopus citations

Abstract

N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) are related neurometabolites used in the diagnosis of a variety of CNS pathologies and neurological disorders. NAA is one of the most concentrated metabolites and NAAG is one of the most concentrated neuroactive peptides in the brain. NAA is best known as a neuronal integrity marker in magnetic resonance spectroscopy (MRS) studies where NAA represents the largest peak on spectrograms of healthy human brain. NAAG can also be detected by MRS. NAA and NAAG are present predominantly in neurons and therefore MRS can be used to noninvasively monitor neuronal health and viability by quantifying the levels of these metabolites. NAA and NAAG levels are changed in a number of neuropsychiatric disorders, and a growing body of evidence suggests that both of these related metabolites may have roles in mediating or modulating higher brain functions.

Original languageEnglish
Title of host publicationMagnetic Resonance Spectroscopy
Subtitle of host publicationTools for Neuroscience Research and Emerging Clinical Applications
PublisherElsevier Inc.
Pages71-90
Number of pages20
ISBN (Print)9780124016880
DOIs
StatePublished - Dec 2013

Keywords

  • Canavan's disease
  • MRS
  • NAA
  • NAAG
  • Neuropsychiatric disorders

Fingerprint

Dive into the research topics of 'N-Acetylaspartate and N-Acetylaspartylglutamate in Central Nervous System Health and Disease'. Together they form a unique fingerprint.

Cite this